CBIZ Investment Advisory Services’s iRadimed IRMD Stock Holding History

CBIZ Investment Advisory Services’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-307	Closed	-$29.9K	–	587
2025 Q4	$29.9K	Sell	307 -1	-0.3%	-$86	﹤0.01%	203
2025 Q3	$21.9K	Sell	308 -2	-0.6%	-$133	﹤0.01%	242
2025 Q2	$18.5K	Buy	310 +1	+0.3%	+$55	﹤0.01%	274
2025 Q1	$16.2K	Buy	309 +48	+18%	+$2.7K	﹤0.01%	260
2024 Q4	$14.3K	Buy	261 +73	+39%	+$3.84K	﹤0.01%	251
2024 Q3	$9.48K	Buy	188 +11	+6%	+$507	﹤0.01%	267
2024 Q2	$7.79K	Hold	177	–	–	﹤0.01%	272
2024 Q1	$7.79K	Buy	+177	New	+$7.82K	﹤0.01%	268

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBIZ Investment Advisory Services's IRMD Position: Q1 2026 in Review

CBIZ Investment Advisory Services sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 307 shares — an estimated $29.9K sold.

CBIZ Investment Advisory Services first reported a position in IRMD in Q1 2024 and held it in 8 quarters. The position peaked at $29.9K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

CBIZ Investment Advisory Services reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
CBIZ Investment Advisory Services sold 307 iRadimed shares in Q1 2026, an estimated $29.9K.
CBIZ Investment Advisory Services first reported a position in iRadimed in Q1 2024 and held it in 8 quarters.
CBIZ Investment Advisory Services's iRadimed position peaked at $29.9K in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.